1. Home
  2. AZTR vs TGL Comparison

AZTR vs TGL Comparison

Compare AZTR & TGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AZTR
  • TGL
  • Stock Information
  • Founded
  • AZTR 2014
  • TGL 2020
  • Country
  • AZTR United States
  • TGL United States
  • Employees
  • AZTR N/A
  • TGL N/A
  • Industry
  • AZTR Biotechnology: Pharmaceutical Preparations
  • TGL Retail: Computer Software & Peripheral Equipment
  • Sector
  • AZTR Health Care
  • TGL Technology
  • Exchange
  • AZTR Nasdaq
  • TGL Nasdaq
  • Market Cap
  • AZTR 3.7M
  • TGL 4.1M
  • IPO Year
  • AZTR 2023
  • TGL 2022
  • Fundamental
  • Price
  • AZTR $0.16
  • TGL $1.27
  • Analyst Decision
  • AZTR
  • TGL
  • Analyst Count
  • AZTR 0
  • TGL 0
  • Target Price
  • AZTR N/A
  • TGL N/A
  • AVG Volume (30 Days)
  • AZTR 1.0M
  • TGL 550.1K
  • Earning Date
  • AZTR 08-11-2025
  • TGL 08-25-2025
  • Dividend Yield
  • AZTR N/A
  • TGL N/A
  • EPS Growth
  • AZTR N/A
  • TGL N/A
  • EPS
  • AZTR N/A
  • TGL N/A
  • Revenue
  • AZTR N/A
  • TGL $1,468,790.00
  • Revenue This Year
  • AZTR N/A
  • TGL N/A
  • Revenue Next Year
  • AZTR N/A
  • TGL N/A
  • P/E Ratio
  • AZTR N/A
  • TGL N/A
  • Revenue Growth
  • AZTR N/A
  • TGL N/A
  • 52 Week Low
  • AZTR $0.14
  • TGL $0.88
  • 52 Week High
  • AZTR $0.80
  • TGL $116.00
  • Technical
  • Relative Strength Index (RSI)
  • AZTR 33.84
  • TGL 59.68
  • Support Level
  • AZTR $0.14
  • TGL $0.97
  • Resistance Level
  • AZTR $0.16
  • TGL $1.32
  • Average True Range (ATR)
  • AZTR 0.01
  • TGL 0.11
  • MACD
  • AZTR -0.00
  • TGL 0.04
  • Stochastic Oscillator
  • AZTR 26.81
  • TGL 88.64

About AZTR Azitra Inc

Azitra Inc is an early-stage clinical biopharmaceutical company focused on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products. Its discovery platform is screened for naturally occurring bacterial cells with beneficial effects. These microbes are then genomically sequenced and engineered to make cellular therapies, recombinant therapeutic proteins, peptides, and small molecules for the precision treatment of dermatology diseases. The company's product candidates include ATR-12, for treating the orphan disease and Netherton syndrome; ATR-04, a genetically modified strain of S. epidermidis for treating the papulopustular rash; and ATR-01, a potential treatment for ichthyosis vulgaris, a chronic, abnormally dry, scaly skin disease.

About TGL Treasure Global Inc.

Treasure Global Inc has created an online-to-offline e-commerce platform business model offering consumers and merchants instant rebates and affiliate cashback programs, while providing a seamless e-payment solution with rebates in both e-commerce and physical retailers/merchant settings. Its product is an internet application branded ZCITY app, that targets consumers by providing personalized deals based on consumers' purchase history, location and preferences.

Share on Social Networks: